NASDAQ:NRC - Nasdaq - US6373722023 - Common Stock - Currency: USD
NRC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 109 industry peers in the Health Care Providers & Services industry. While NRC has a great profitability rating, there are some minor concerns on its financial health. NRC is valued correctly, but it does not seem to be growing.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 20.54% | ||
ROE | 78.2% | ||
ROIC | 30.89% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 26.12% | ||
PM (TTM) | 18.78% | ||
GM | 60.89% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.44 | ||
Debt/FCF | 2.13 | ||
Altman-Z | 3.68 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.47 | ||
Quick Ratio | 0.47 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.24 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 12.88 | ||
EV/EBITDA | 8.76 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.31% |
NASDAQ:NRC (3/3/2025, 2:51:20 PM)
14.055
-0.54 (-3.67%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.31% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.24 | ||
Fwd PE | N/A | ||
P/S | 2.25 | ||
P/FCF | 12.88 | ||
P/OCF | 8.12 | ||
P/B | 9.37 | ||
P/tB | N/A | ||
EV/EBITDA | 8.76 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 20.54% | ||
ROE | 78.2% | ||
ROCE | 43.03% | ||
ROIC | 30.89% | ||
ROICexc | 32.09% | ||
ROICexgc | 141.93% | ||
OM | 26.12% | ||
PM (TTM) | 18.78% | ||
GM | 60.89% | ||
FCFM | 17.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 1.44 | ||
Debt/FCF | 2.13 | ||
Debt/EBITDA | 1.14 | ||
Cap/Depr | 248.91% | ||
Cap/Sales | 10.25% | ||
Interest Coverage | 19.8 | ||
Cash Conversion | 91.64% | ||
Profit Quality | 92.99% | ||
Current Ratio | 0.47 | ||
Quick Ratio | 0.47 | ||
Altman-Z | 3.68 |